Therefore, considering the presence of APAP protein adducts at the therapeutic dose of APAP, formation of protein adducts on mitochondrial proteins rather than the overall formation of protein adducts may be the reason for cellular toxicity, which has been considered a key factor for necrotic cell death in previous years (Jollow et al., 1973
That data wasnt always included in the FDA scientists presentations a decision that rankled some committee members
Following is what I found in the research
First described in the mid-1990s, it is classified as a growth hormone secretagogue (GHS), a category of compounds designed to interact with the ghrelin/GHS receptor
It acts as an amylin receptor agonist, activating AMY1, AMY2, and AMY3 receptors heterodimers of the calcitonin receptor with receptor activity-modifying proteins (RAMPs) to produce satiety signaling, gastric emptying inhibition, and glucagon suppression
Benefits: Combines multiple antioxidants for comprehensive skin health
